Microarray Analyses Reveal Marked Differences in Growth Factor and Receptor Expression between 8-Cell Human Embryos and Pluripotent Stem Cells

Stem Cells and Development

Volumn 25, Issue 2, 2016, Pages 160-177

  Vlismas, Antonis ^a   Bletsa, Ritsa ^a   Mavrogianni, Despina ^a   Mamali, Georgina ^a   Pergamali, Maria ^a   Dinopoulou, Vasiliki ^a,b   Partsinevelos, George ^a   Drakakis, Peter ^a   Loutradis, Dimitris ^a   Kiessling, Ann A ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b Bedford Stem Cell Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 15; BONE MORPHOGENETIC PROTEIN 6; CD36 ANTIGEN; COLONY STIMULATING FACTOR RECEPTOR; ENDOGLIN; FIBROBLAST GROWTH FACTOR 14; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GROWTH DIFFERENTIATION FACTOR 9; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; GROWTH FACTOR RECEPTOR BOUND PROTEIN 7; INSULIN RECEPTOR; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 3 RECEPTOR; INTERLEUKIN 4; LEFT RIGHT DETERMINATION FACTOR 1; LEFT RIGHT DETERMINATION FACTOR 2; NERVE GROWTH FACTOR; NEU DIFFERENTIATION FACTOR; OSTEOGENIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TERATOCARCINOMA DERIVED GROWTH FACTOR 1; TERATOCARCINOMA DERIVED GROWTH FACTOR 3; UNCLASSIFIED DRUG; VASCULOTROPIN; WNT6 PROTEIN; FIBROBLAST GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE CHECKPOINT; CELL DIFFERENTIATION; CELL DIVISION; CIRCADIAN RHYTHM; CONTROLLED STUDY; ECTODERM; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN EMBRYONIC STEM CELL; IMMUNE RESPONSE; MICROARRAY ANALYSIS; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL CULTURE; CELL CYCLE; CYTOLOGY; DNA MICROARRAY; METABOLISM; PHYSIOLOGY; PREGNANCY; TISSUE MICROARRAY;

CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; FEMALE; FIBROBLAST GROWTH FACTORS; FIBROBLASTS; GENE EXPRESSION; HUMAN EMBRYONIC STEM CELLS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLURIPOTENT STEM CELLS; PREGNANCY; TISSUE ARRAY ANALYSIS;

EID: 84954434210     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2015.0284     Document Type: Article

References (89)

1. Kiessling AA, R Bletsa, B Desmarais, C Mara, K Kallianidis and D Loutradis. (2009). Evidence that human blastomere cleavage is under unique cell cycle control. J Assist Reprod Genet 26:187-195.
2. Kiessling AA, R Bletsa, B Desmarais, C Mara, K Kallianidis and D Loutradis. (2010). Genome-wide microarray evidence that 8-cell human blastomeres over-express cell cycle drivers and under-express checkpoints. J Assist Reprod Genet 27:265-276.
3. Kaye PL. (1997). Preimplantation growth factor physiology. Rev Reprod 2:121-127.
4. Hardy K and S Spanos. (2002). Growth factor expression and function in the human and mouse preimplantation embryo. J Endocrinol 172:221-236.
5. Richter KS. (2008). The importance of growth factors for preimplantation embryo development and in-vitro culture. Curr Opin Obstet Gynecol 20:292-304.
6. Diaz-Cueto L and GL Gerton. (2001). The influence of growth factors on the development of preimplantation mammalian embryos. Arch Med Res 32:619-626.
7. Kane MT, PM Morgan and C Coonan. (1997). Peptide growth factors and preimplantation development. Hum Reprod Update 3:137-157.
8. Sharkey AM, K Dellow, M Blayney, M Macnamee, S Charnock-Jones and SK Smith. (1995). Stage-specific expression of cytokine and receptor messenger ribonucleic acids in human preimplantation embryos. Biol Reprod 53:974-981.
9. Lighten AD, K Hardy, RM Winston and GE Moore. (1997). Expression of mRNA for the insulin-like growth factors and their receptors in human preimplantation embryos. Mol Reprod Dev 47:134-139.
10. Kimber SJ, SF Sneddon, DJ Bloor, AM El-Bareg, JA Hawkhead, AD Metcalfe, FD Houghton, HJ Leese, A Rutherford, BA Lieberman and DR Brison. (2008). Expression of genes involved in early cell fate decisions in human embryos and their regulation by growth factors. Reproduction 135:635-647.
11. Cauffman G, M De Rycke, K Sermon, I Liebaers and H Van de Velde. (2009). Markers that define stemness in ESC are unable to identify the totipotent cells in human preimplantation embryos. Hum Reprod 24:63-70.
12. Smotrich DB, RJ Stillman, EA Widra, PR Gindoff, P Kaplan, M Graubert and KE Johnson. (1996). Immunocytochemical localization of growth factors and their receptors in human pre-embryos and Fallopian tubes. Hum Reprod 11:184-190.
13. Galan A, D Montaner, ME Poo, D Valbuena, V Ruiz, C Aguilar, J Dopazo and C Simon. (2010). Functional genomics of 5-to 8-cell stage human embryos by blastomere single-cell cDNA analysis. PLoS One 5:e13615.
14. Kocabas AM, J Crosby, PJ Ross, HH Otu, Z Beyhan, H Can, WL Tam, GJ Rosa, RG Halgren, et al. (2006). The transcriptome of human oocytes. Proc Natl Acad Sci USA 103:14027-14032.
15. Shaw L, SF Sneddon, L Zeef, SJ Kimber and DR Brison. (2013). Global gene expression profiling of individual human oocytes and embryos demonstrates heterogeneity in early development. PLoS One 8:e64192.
16. Canales RD, Y Luo, JC Willey, B Austermiller, CC Barbacioru, C Boysen, K Hunkapiller, RV Jensen, CR Knight, et al. (2006). Evaluation of DNA microarray results with quantitative gene expression platforms. Nat Biotechnol 24:1115-1122.
17. Consortium M, L Shi, LH Reid, WD Jones, R Shippy, JA Warrington, SC Baker, PJ Collins, F de Longueville, et al. (2006). The MicroArray Quality Control (MAQC) project shows inter-and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24:1151-1161.
18. Morey JS, JC Ryan and FM Van Dolah. (2006). Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biol Proced Online 8:175-193.
19. Zhang P, M Zucchelli, S Bruce, F Hambiliki, A Stavreus-Evers, L Levkov, H Skottman, E Kerkela, J Kere and O Hovatta. (2009). Transcriptome profiling of human preimplantation development. PLoS One 4:e7844.
20. Kiessling AA. (2010). Timing is everything in the human embryo. Nat Biotechnol 28:1025-1026.
21. Tanaka TS and MS Ko. (2004). A global view of gene expression in the preimplantation mouse embryo: morula versus blastocyst. Eur J Obstet Gynecol Reprod Biol 115 Suppl 1:S85-S91.
22. Lin SC, SX Skapek and EY Lee. (1996). Genes in the RB pathway and their knockout in mice. Semin Cancer Biol 7:279-289.
23. Pizarro A, K Hayer, NF Lahens and JB Hogenesch. (2013). CircaDB: a database of mammalian circadian gene expression profiles. Nucleic Acids Res 41:D1009-D1013.
24. Wells A. (1999). EGF receptor. Int J Biochem Cell Biol 31:637-643.
25. Falls DL. (2003). Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 284:14-30.
26. Harris RC, E Chung and RJ Coffey. (2003). EGF receptor ligands. Exp Cell Res 284:2-13.
27. Wesche J, K Haglund and EM Haugsten. (2011). Fibroblast growth factors and their receptors in cancer. Biochem J 437:199-213.
28. Zhang F, Z Zhang, X Lin, A Beenken, AV Eliseenkova, M Mohammadi and RJ Linhardt. (2009). Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes. Biochemistry 48:8379-8386.
29. Knight PG and C Glister. (2006). TGF-beta superfamily members and ovarian follicle development. Reproduction 132:191-206.
30. Tesar PJ, JG Chenoweth, FA Brook, TJ Davies, EP Evans, DL Mack, RL Gardner and RD McKay. (2007). New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448:196-199.
31. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
32. GeneMANIA.org Nucleic Acids Research. (2010). Jul 1; 38 Suppl: W214-20.
33. DAVID. (2008). ncifcrf.gov Nature Protocols 4:44-57.
34. Jackson KV and AA Kiessling. (1989). Fertilization and cleavage of mouse oocytes exposed to the conditions of human oocyte retrieval for in vitro fertilization. Fertil Steril 51:675-681.
35. Loutradis D, D John and AA Kiessling. (1987). Hypoxanthine causes a 2-cell block in random-bred mouse embryos. Biol Reprod 37:311-316.
36. Nureddin A, E Epsaro and AA Kiessling. (1990). Purines inhibit the development of mouse embryos in vitro. J Reprod Fertil 90:455-464.
37. Klimanskaya I, Y Chung, S Becker, SJ Lu and R Lanza. (2006). Human embryonic stem cell lines derived from single blastomeres. Nature 444:481-485.
38. Wakayama S, T Hikichi, R Suetsugu, Y Sakaide, HT Bui, E Mizutani and T Wakayama. (2007). Efficient establishment of mouse embryonic stem cell lines from single blastomeres and polar bodies. Stem Cells 25:986-993.
39. Mitalipova M, Z Beyhan and NL First. (2001). Pluripotency of bovine embryonic cell line derived from precompacting embryos. Cloning 3:59-67.
40. Kort J, R Lathi, K Brookfield, V Baker, Q Zhao and B Behr. (2015). Aneuploidy rates and blastocyst formation after biopsy of morulae and early blastocysts on day 5. Journal of Assisted Reproduction and Genetics 32:925-930.
41. Chia CM, RM Winston and AH Handyside. (1995). EGF, TGF-alpha and EGFR expression in human preimplantation embryos. Development 121:299-307.
42. Loutradis D, GA Koussidis, R Bletsa, S Milingos, A Antsaklis and S Michalas. (2005). EGF and IGF-I as predictors of ICSI outcome in human preimplantation embryo cultures. Clin Exp Obstet Gynecol 32:166-168.
43. Itoh M, Y Yoshida, K Nishida, M Narimatsu, M Hibi and T Hirano. (2000). Role of Gab1 in heart, placenta, and skin development and growth factor-and cytokine-induced extracellular signal-regulated kinase mitogen-activated protein kinase activation. Mol Cell Biol 20:3695-3704.
44. Odiete O, MF Hill and DB Sawyer. (2012). Neuregulin in cardiovascular development and disease. Circ Res 111: 1376-1385.
45. Charles C, V Lazzari, P Tafforeau, T Schimmang, M Tekin, O Klein and L Viriot. (2009). Modulation of Fgf3 dosage in mouse and men mirrors evolution of mammalian dentition. Proc Natl Acad Sci USA 106:22364-22368.
46. Koch P, HB Lohr and W Driever. (2014). A mutation in cnot8, component of the Ccr4-not complex regulating transcript stability, affects expression levels of developmental regulators and reveals a role of Fgf3 in development of caudal hypothalamic dopaminergic neurons. PLoS One 9:e113829.
47. Rossi P and S Dolci. (2013). Paracrine mechanisms involved in the control of early stages of Mammalian spermatogenesis. Front Endocrinol (Lausanne) 4:181.
48. Yin Y, AM Castro, M Hoekstra, TJ Yan, AC Kanakamedala, LP Dehner, DA Hill and DM Ornitz. (2015). Fibroblast growth factor 9 regulation by MicroRNAs controls lung development and links DICER1 loss to the pathogenesis of pleuropulmonary blastoma. PLoS Genet 11: e1005242.
49. Wu QF, L Yang, S Li, Q Wang, XB Yuan, X Gao, L Bao and X Zhang. (2012). Fibroblast growth factor 13 is a microtubule-stabilizing protein regulating neuronal polarization and migration. Cell 149:1549-1564.
50. Laezza F, BR Gerber, JY Lou, MA Kozel, H Hartman, AM Craig, DM Ornitz and JM Nerbonne. (2007). The FGF14(F145S) mutation disrupts the interaction of FGF14 with voltage-gated Na+ channels and impairs neuronal excitability. J Neurosci 27:12033-12044.
51. Brusse E, I de Koning, A Maat-Kievit, BA Oostra, P Heutink and JC van Swieten. (2006). Spinocerebellar ataxia associated with a mutation in the fibroblast growth factor 14 gene (SCA27): a new phenotype. Mov Disord 21:396-401.
52. van Swieten JC, E Brusse, BM de Graaf, E Krieger, R van de Graaf, I de Koning, A Maat-Kievit, P Leegwater, D Dooijes, BA Oostra and P Heutink. (2003). A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia [corrected]. Am J Hum Genet 72:191-199.
53. Shavkunov AS, NC Wildburger, MN Nenov, TF James, TP Buzhdygan, NI Panova-Elektronova, TA Green, RL Veselenak, N Bourne and F Laezza. (2013). The fibroblast growth factor 14.voltage-gated sodium channel complex is a new target of glycogen synthase kinase 3 (GSK3). J Biol Chem 288:19370-19385.
54. Lian X, X Bao, A Al-Ahmad, J Liu, Y Wu, W Dong, KK Dunn, EV Shusta and SP Palecek. (2014). Efficient differentiation of human pluripotent stem cells to endothelial progenitors via small-molecule activation of WNT signaling. Stem Cell Reports 3:804-816.
55. Sato N, L Meijer, L Skaltsounis, P Greengard and AH Brivanlou. (2004). Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 10:55-63.
56. Hemmings R, J Langlais, T Falcone, L Granger, P Miron and H Guyda. (1992). Human embryos produce transforming growth factors alpha activity and insulin-like growth factors II. Fertil Steril 58:101-104.
57. Han VK, N Bassett, J Walton and JR Challis. (1996). The expression of insulin-like growth factor (IGF) and IGFHUMANbinding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. J Clin Endocrinol Metab 81:2680-2693.
58. Koutsaki M, S Sifakis, A Zaravinos, D Koutroulakis, O Koukoura and DA Spandidos. (2011). Decreased placental expression of hPGH, IGF-I and IGFBP-1 in pregnancies complicated by fetal growth restriction. Growth Horm IGF Res 21:31-36.
59. Saso J, SK Shields, Y Zuo and C Chakraborty. (2012). Role of Rho GTPases in human trophoblast migration induced by IGFBP1. Biol Reprod 86:1-9.
60. Brummer T, M Larance, MT Herrera Abreu, RJ Lyons, P Timpson, CH Emmerich, ED Fleuren, GM Lehrbach, D Schramek, et al. (2008). Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein. EMBO J 27:2305-2316.
61. Takahashi M, F Otsuka, T Miyoshi, H Otani, J Goto, M Yamashita, T Ogura, H Makino and H Doihara. (2008). Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation. J Endocrinol 199:445-455.
62. DiLeone RJ, JA King, EE Storm, NG Copeland, NA Jenkins and DM Kingsley. (1997). The Bmp8 gene is expressed in developing skeletal tissue and maps near the Achondroplasia locus on mouse chromosome 4. Genomics 40:196-198.
63. Ying Y, X Qi and GQ Zhao. (2002). Induction of primordial germ cells from pluripotent epiblast. ScientificWorldJournal 2:801-810.
64. Solloway MJ, AT Dudley, EK Bikoff, KM Lyons, BL Hogan and EJ Robertson. (1998). Mice lacking Bmp6 function. Dev Genet 22:321-339.
65. Tanwar PS and JR McFarlane. (2011). Dynamic expression of bone morphogenetic protein 4 in reproductive organs of female mice. Reproduction 142:573-579.
66. Dube JL, P Wang, J Elvin, KM Lyons, AJ Celeste and MM Matzuk. (1998). The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol Endocrinol 12:1809-1817.
67. Zeng F and RM Schultz. (2003). Gene expression in mouse oocytes and preimplantation embryos: use of suppression subtractive hybridization to identify oocyte-and embryospecific genes. Biol Reprod 68:31-39.
68. Hamatani T, T Daikoku, H Wang, H Matsumoto, MG Carter, MS Ko and SK Dey. (2004). Global gene expression analysis identifies molecular pathways distinguishing blastocyst dormancy and activation. Proc Natl Acad Sci USA 101:10326-10331.
69. Pennetier S, S Uzbekova, C Guyader-Joly, P Humblot, P Mermillod and R Dalbies-Tran. (2005). Genes preferentially expressed in bovine oocytes revealed by subtractive and suppressive hybridization. Biol Reprod 73: 713-720.
70. Wilhelm BT, M Briau, P Austin, A Faubert, G Boucher, P Chagnon, K Hope, S Girard, N Mayotte, et al. (2011). RNA-seq analysis of 2 closely related leukemia clones that differ in their self-renewal capacity. Blood 117: e27-e38.
71. Peng J, Q Li, K Wigglesworth, A Rangarajan, C Kattamuri, RT Peterson, JJ Eppig, TB Thompson and MM Matzuk. (2013). Growth differentiation factor 9:bone morphogenetic protein 15 heterodimers are potent regulators of ovarian functions. Proc Natl Acad Sci USA 110:E776-E785.
72. Peng J, Q Li, K Wigglesworth, A Rangarajan, C Kattamuri, RT Peterson, JJ Eppig, TB Thompson and MM Matzuk. (2013). Reply to Mottershead et al.: GDF9:BMP15 heterodimers are potent regulators of ovarian functions. Proc Natl Acad Sci USA 110:E2258.
73. Segklia A, E Seuntjens, M Elkouris, S Tsalavos, E Stappers, TA Mitsiadis, D Huylebroeck, E Remboutsika and D Graf. (2012). Bmp7 regulates the survival, proliferation, and neurogenic properties of neural progenitor cells during corticogenesis in the mouse. PLoS One 7:e34088.
74. D'Andrea D, GL Liguori, JA Le Good, E Lonardo, O Andersson, DB Constam, MG Persico and G Minchiotti. (2008). Cripto promotes A-P axis specification independently of its stimulatory effect on Nodal autoinduction. J Cell Biol 180:597-605.
75. Liguori GL, AC Borges, D D'Andrea, A Liguoro, L Goncalves, AM Salgueiro, MG Persico and JA Belo. (2008). Cripto-independent Nodal signaling promotes positioning of the A-P axis in the early mouse embryo. Dev Biol 315: 280-289.
76. Gregory AL, G Xu, V Sotov and M Letarte. (2014). Review: the enigmatic role of endoglin in the placenta. Placenta 35 Suppl:S93-S99.
77. Borges L, M Iacovino, T Mayerhofer, N Koyano-Nakagawa, J Baik, DJ Garry, M Kyba, M Letarte and RC Perlingeiro. (2012). A critical role for endoglin in the emergence of blood during embryonic development. Blood 119:5417-5428.
78. Banerjee S, SK Dhara and M Bacanamwo. (2012). Endoglin is a novel endothelial cell specification gene. Stem Cell Res 8:85-96.
79. ten Dijke P, MJ Goumans and E Pardali. (2008). Endoglin in angiogenesis and vascular diseases. Angiogenesis 11: 79-89.
80. Gonzalez-Munoz E, Y Arboleda-Estudillo, HH Otu and JB Cibelli. (2014). Cell reprogramming. Histone chaperone ASF1A is required for maintenance of pluripotency and cellular reprogramming. Science 345:822-825.
81. Levine AJ and AH Brivanlou. (2006). GDF3, a BMP inhibitor, regulates cell fate in stem cells and early embryos. Development 133:209-216.
82. Sapoznik S, B Cohen, Y Tzuman, G Meir, S Ben-Dor, A Harmelin and M Neeman. (2009). Gonadotropin-regulated lymphangiogenesis in ovarian cancer is mediated by LEDGF-induced expression of VEGF-C. Cancer Res 69:9306-9314.
83. Takacs P and S Kauma. (1996). The expression of interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor type I mRNA during preimplantation mouse development. J Reprod Immunol 32:27-35.
84. Bourdiec A, E Calvo, CV Rao and A Akoum. (2013). Transcriptome analysis reveals new insights into the modulation of endometrial stromal cell receptive phenotype by embryo-derived signals interleukin-1 and human chorionic gonadotropin: possible involvement in early embryo implantation. PLoS One 8:e64829.
85. Robertson SA, PY Chin, JE Schjenken and JG Thompson. (2015). Female tract cytokines and developmental programming in embryos. Adv Exp Med Biol 843:173-213.
86. Faye MD, TE Graber, P Liu, N Thakor, SD Baird, D Durie and M Holcik. (2013). Nucleotide composition of cellular internal ribosome entry sites defines dependence on NF45 and predicts a posttranscriptional mitotic regulon. Mol Cell Biol 33:307-318.
87. Sasmono RT, D Oceandy, JW Pollard, W Tong, P Pavli, BJ Wainwright, MC Ostrowski, SR Himes and DA Hume. (2003). A macrophage colony-stimulating factor receptorgreen fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 101:1155-1163.
88. van Vliet SJ, S Bay, IM Vuist, H Kalay, JJ Garcia-Vallejo, C Leclerc and Y van Kooyk. (2013). MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-alpha secretion. J Leukoc Biol 94:315-323.
89. Dunglison GF, DH Barlow and IL Sargent. (1996). Leukaemia inhibitory factor significantly enhances the blastocyst formation rates of human embryos cultured in serum-free medium. Hum Reprod 11:191-196.